TITLE

Spinosad Topical Suspension 0.9% (Natroba)

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
February 2011
SOURCE
Internal Medicine Alert;2/28/2011, Vol. 33 Issue 4, p30
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the indication, dosage, and effectiveness of Spinosad Topical Suspension 0.9%, a topical treatment for head lice infestation.
ACCESSION #
59522688

 

Related Articles

  • Mometasone Furoate and Formoterol Fumarate Inhalation Aerosol (Dulera). Elliott, William T.; Chan, James // Internal Medicine Alert;9/1/2010, Vol. 32 Issue 18, p142 

    The article offers information on the indications, recommended dosage and clinical implications of mometasone furoate (MF) and formoterol.

  • Spectrophotometric estimation of purlifloxacin in bulk and pharmaceutical dosage form by UV spectrophotometry. Dey, Suddhasattya; Samal, Himansu Bhusan; Kumar, Dhiraj; Vaidanathanan, S.; Ratnakar, C. H.; Mohapatra, Subhasis; Patnaik, Ansuman; Kumar, D. Bharat // Drug Invention Today;Oct2010, Vol. 2 Issue 10, p454 

    The present study describes a simple, accurate, precise and cost effective UV-VIS Spectrophotometric method for the estimation of PURLIFLOXACIN, a fluroquinolone derivative, in bulk and pharmaceutical dosage form. The solvent used was 0.1NNaoH and thelmax or the absorption maxima of the drug was...

  • ENTRY FORMAT.  // Monthly Prescribing Reference;Jul2011, Vol. 27 Issue 7, pA.6 

    A chapter of the book "Monthly Prescribing Reference" is presented. It presents the format for the submission of entry for monograph on drug at "Monthly Prescribing Reference." It requires the entry to include the main name under which the product and all other dosage forms in the monograph are...

  • Current FDA-Related Drug Information. Baker, Danial E. // Hospital Pharmacy;Jan2007, Vol. 42 Issue 1, p74 

    Several tables are presented that provide information on new drugs approved by the U.S. Food and Drug Administration (FDA), new dosage forms and indications, agents with pending FDA approval and labeling changes related to drug safety.

  • The safest treatment for kids with head lice.  // HealthFacts;Mar96, Vol. 21 Issue 202, p3 

    Focuses on treating children with head lice. Use of Nix, an over-the-counter-drug to treat head lice; Adverse reactions to lice drugs.

  • Head lice alarm. Gilbert, Susan // Redbook;Mar96, Vol. 186 Issue 5, p146 

    Offers advice on how to treat head lice infestation in children.

  • Labeling change for lindane lice treatments.  // FDA Consumer;Jun96, Vol. 30 Issue 5, p5 

    Reports on the revised labeling for lice and scabies treatments containing lindane. Regulation under the US Food & Drug Administration; Health risks of the treatment.

  • Systematic review of clinical efficacy of topical treatments for head lice. Stichele, Robert H. Vande; Dezeure, Ela M. // BMJ: British Medical Journal (International Edition);9/2/95, Vol. 311 Issue 7005, p604 

    Evaluates the clinical efficiency of topical treatments for head lice. Head lice as the most common of human ectoparasites; Measurement of clinical efficacy of the treatments; Composition of anti-lice shampoos tested; Active ingredients; Recommendations for future studies.

  • Are head lice becoming resistant to treatment?  // Child Health Alert;Jan1996, Vol. 14, p1 

    Discusses the management of head lice infestations, mostly in children. Suggestion from National Pediculosis Association in preventing outbreaks; Preventing transmission; Concerns over the possible resistance of head lice to some of the agents used to treat them.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics